The promise and pitfalls of mass drug administration to control intestinal helminth infections

Purpose of reviewIntestinal helminth infections continue to cause significant morbidity in resource-limited settings. Recent efforts at global control have centered on mass drug administration (MDA) of praziquantel and benzimidazole anthelminthics to reduce the prevalence and intensity of schistosom